> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Draft Guide on Noncirrhotic Nonalcoholic Steatohepatitis Drugs
- URL: https://www.fdaweb.com/draft-guide-on-noncirrhotic-nonalcoholic-steatohepatitis-drugs/
- Published: 2018-12-04T12:00:00.000Z
- Updated: 2026-09-15T00:48:24.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5142957

*Federal Register* notice: FDA has made available a draft guidance entitled “Noncirrhotic Nonalcoholic Steatohepatitis With Liver Fibrosis: Developing Drugs for Treatment.” The document identifies knowledge gaps that represent important challenges in developing such drugs. To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2018-12-04/pdf/2018-26333.pdf?ref=fdaweb.com).